Bradley Pharmaceuticals Appoints David Wong Senior Vice President Global Sales and Market Development

Apr 23, 2001, 01:00 ET from Bradley Pharmaceuticals, Inc.

    FAIRFIELD, N.J., April 23 /PRNewswire Interactive News Release/ --
 BRADLEY PHARMACEUTICALS, INC. (Nasdaq:   BPRX) announced the appointment of
 David Wong as Senior Vice President Global Sales and Market Development for
 Bradley Pharmaceuticals.
     Mr. Wong will be responsible for all phases of sales activities, including
 Sales Training, Development, Administration, Telemarketing and International
 Distribution.
     David has over twenty years' experience.  Most recently, he held the
 position of Vice President of Global Brand Strategy and Marketing for 24/7
 Media Inc.  Previously, he served as General Manager of the Business to
 Business Small Business Markets Division of AT&T for five years.  David has
 extensive experience in overseeing sales teams and marketing groups.
     Bradley Pharmaceuticals President & CEO, Daniel Glassman, stated, "We are
 very pleased to welcome David to the Bradley Pharmaceuticals Management Team.
 His experience in national and international market development and sales
 management will be invaluable as Bradley continues to implement an aggressive
 growth strategy in the US and abroad. We are confident that David's expertise
 will help the Company achieve the ambitious goals management has set for 2001,
 and beyond."
     Please visit Bradley Pharmaceuticals web site at:
 http://www.bradpharm.com.
 
     Bradley Pharmaceuticals markets prescription and ethically-promoted
 non-prescription drugs throughout the US and in 31 international markets.
 Bradley delivers gastroenterology, nutritional and respiratory brands through
 its Kenwood Therapeutics division, and dermatology brands through its Doak
 Dermatologics subsidiary. The Company remains focused on core strengths of
 marketing, sales and financial control, and has achieved success by targeting
 unfilled marketing opportunities and introducing product line extensions to
 fill unmet needs.
 
     Important announcement:
     First Quarter 2001 Earnings will be released on Thursday, April 26, 2001
 at 9 am EST.
 
     Bradley Pharmaceuticals common stock is quoted on the NASDAQ market under
 the symbol BPRX.
 
     This release may contain forward-looking statements that reflect
 management's current views of future events and operations. These forward-
 looking statements are based on assumptions and external factors, including
 assumptions relating to regulatory action, capital requirements and competing
 products. The occurrence of actual events may differ materially due to a
 variety of factors, including customer acceptance and competitive pressures.
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X64071820
 
 

SOURCE Bradley Pharmaceuticals, Inc.
    FAIRFIELD, N.J., April 23 /PRNewswire Interactive News Release/ --
 BRADLEY PHARMACEUTICALS, INC. (Nasdaq:   BPRX) announced the appointment of
 David Wong as Senior Vice President Global Sales and Market Development for
 Bradley Pharmaceuticals.
     Mr. Wong will be responsible for all phases of sales activities, including
 Sales Training, Development, Administration, Telemarketing and International
 Distribution.
     David has over twenty years' experience.  Most recently, he held the
 position of Vice President of Global Brand Strategy and Marketing for 24/7
 Media Inc.  Previously, he served as General Manager of the Business to
 Business Small Business Markets Division of AT&T for five years.  David has
 extensive experience in overseeing sales teams and marketing groups.
     Bradley Pharmaceuticals President & CEO, Daniel Glassman, stated, "We are
 very pleased to welcome David to the Bradley Pharmaceuticals Management Team.
 His experience in national and international market development and sales
 management will be invaluable as Bradley continues to implement an aggressive
 growth strategy in the US and abroad. We are confident that David's expertise
 will help the Company achieve the ambitious goals management has set for 2001,
 and beyond."
     Please visit Bradley Pharmaceuticals web site at:
 http://www.bradpharm.com.
 
     Bradley Pharmaceuticals markets prescription and ethically-promoted
 non-prescription drugs throughout the US and in 31 international markets.
 Bradley delivers gastroenterology, nutritional and respiratory brands through
 its Kenwood Therapeutics division, and dermatology brands through its Doak
 Dermatologics subsidiary. The Company remains focused on core strengths of
 marketing, sales and financial control, and has achieved success by targeting
 unfilled marketing opportunities and introducing product line extensions to
 fill unmet needs.
 
     Important announcement:
     First Quarter 2001 Earnings will be released on Thursday, April 26, 2001
 at 9 am EST.
 
     Bradley Pharmaceuticals common stock is quoted on the NASDAQ market under
 the symbol BPRX.
 
     This release may contain forward-looking statements that reflect
 management's current views of future events and operations. These forward-
 looking statements are based on assumptions and external factors, including
 assumptions relating to regulatory action, capital requirements and competing
 products. The occurrence of actual events may differ materially due to a
 variety of factors, including customer acceptance and competitive pressures.
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X64071820
 
 SOURCE  Bradley Pharmaceuticals, Inc.